Your browser doesn't support javascript.
loading
An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2.
Ravichandran, Kameswaran; Zafar, Iram; He, Zhibin; Doctor, R Brian; Moldovan, Radu; Mullick, Adam E; Edelstein, Charles L.
Afiliação
  • Ravichandran K; Division of Renal Diseases and Hypertension.
  • Zafar I; Division of Renal Diseases and Hypertension.
  • He Z; Division of Renal Diseases and Hypertension.
  • Doctor RB; Division of Hepatology.
  • Moldovan R; Advanced Light Microscopy Core Facility, University of Colorado at Denver, Aurora, CO, USA.
  • Mullick AE; ISIS Pharmaceuticals, Carlsbad, CA, USA.
  • Edelstein CL; Division of Renal Diseases and Hypertension, charles.edelstein@ucdenver.edu.
Hum Mol Genet ; 23(18): 4919-31, 2014 Sep 15.
Article em En | MEDLINE | ID: mdl-24847003

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligonucleotídeos Antissenso / Canais de Cátion TRPP / Serina-Treonina Quinases TOR / Doenças Renais Policísticas Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligonucleotídeos Antissenso / Canais de Cátion TRPP / Serina-Treonina Quinases TOR / Doenças Renais Policísticas Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article